Notice

Viral vector production for cell and gene therapies

UK businesses can apply for up to £16 million to grow manufacturing capacity for UK viral vector use in advanced therapy medicinal products.

• From: Innovate UK
• Published: 23 October 2017

This publication was withdrawn on 17 January 2018

This competition is no longer open for applications. Search current funding opportunities.

Documents

Competition guidance: viral vector production for cell and gene therapies

HTML

Details

To lead a project you must:

• be a UK-based business of any size
• manufacture viral vectors either:
  • to good manufacturing practice (GMP) standards as gene therapies
  • for viral transduction to generate gene-modified cell therapies

Please read the competition scope and guidance for applicants for this competition before you apply.

Published 23 October 2017